15 Feb 2017 11:29
Â
Collagen Solutions plc
("Collagen Solutions", the "Company" or the "Group")
Â
15 February 2017
Grant of Options
Â
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that options over 500,000 ordinary shares of 1p each in the Company ("Ordinary Shares") were granted today to Kevin Darling, General Manager (New Zealand) ("Options").
Â
The Options have an exercise period of ten years from grant and have an exercise price per Option of 5.625p. The Options vest in full upon the closing middle market price per Ordinary Share exceeding 27p or EPS for the relevant financial year achieving 1p during the exercise period.
Â
- Ends -
Â
Enquiries:
 Collagen Solutions Plc | Contact via Walbrook | ||
Jamal Rushdy, Chief Executive Officer | |||
Gill Black, Chief Financial Officer | |||
Cenkos Securities plc (Nominated Adviser and Broker) Stephen Keys Steve Cox Callum Davidson | Tel: 0207 397 8900 Â Â | ||
Walbrook PR | Tel: 020 7933 8780 or collagen@walbrookpr.com | ||
Mike Wort | Mob: 07900 608 002 | ||
Anna Dunphy | Mob: 07876 741 001 | ||
Â
Â
Â
Â
1  | Details of the person discharging managerial responsibilities / person closely associated  | |
a)  | Name   | Kevin Darling |
2  | Reason for the notification  | |
a)  | Position/status   | General Manager, New Zealand - Executive Team Member |
b)  | Initial notification /Amendment   |  Initial Notification |
3  | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  | |
a)  | Name   | Collagen Solutions Plc  |
b) Â | LEI Â Â | N/A |
4  | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  | |
a)  | Description of the financial instrument, type of instrument   Identification code  |  Option to acquire 1p ordinary shares in Collagen Solutions Plc  N/A  |
b)  | Nature of the transaction   | Grant of Options |
c) Â | Price(s) and volume(s) Â Â | Price (exercise): 5.625p Volume(s): 500,000 Â |
d)  | Aggregated information  - Aggregated volume  - Price  |   N/A  N/A  |
e)  | Date of the transaction   | 15 February 2017 |
f)  | Place of the transaction   | Outside a trading venue |
Â